日本ベクトン・ディッキンソン 品質管理・研究開発・注射剤の製剤研究・CMO Official site

Environmental Microorganism <Surface-Attached Bacteria> Testing BD Rodac™ Plate

We use secure lid petri dishes with protrusions that fix the lid and base together, providing ease of handling and reducing contamination risk.

By using BD RODAC™ plates, microbial contamination of the working environment, such as the surfaces of instruments and equipment, can be easily monitored. The RODAC method is the most widely adopted method internationally. Furthermore, the various media used in BD BBL BD RODAC™ plates comply with the composition standards of the American Public Health Association (APHA) and are strictly quality controlled. By using this highly reliable BD RODAC™ plate agar for environmental and food hygiene assessments, high testing accuracy can be expected.

Related Link - https://www.bdj.co.jp/micro/lp_industrial_bbl_difc…

basic information

【Published Content】 BD Rodac™ Plate SCD Agar Medium BD Rodac™ Plate SCDLP Agar Medium BD Rodac™ Plate Standard Agar Medium BD Rodac™ Plate Deoxycholate Agar Medium BD Rodac™ Plate Egg Yolk Mannitol Salt Agar Medium BD Rodac™ Plate CP Added Sabouraud Agar Medium BD Rodac™ Plate CP Added Potato Agar Medium BD Rodac™ Plate CHROMAGAR™ ECC Agar Medium ★For product details, please visit our website.

Price information

Please feel free to contact us.

Price range

P1

Delivery Time

OTHER

[Order Management Department] 0120-8555-90 (Voice Guidance: Option 1)

Applications/Examples of results

Please contact us.

Performance verification of BD BBL(TM) SCD agar group.

APPLICATION_NOTE

Recommended products

Distributors

BD Japan is the Japanese subsidiary of BD, one of the world's leading medical device and medtech companies headquartered in New Jersey, USA. BD aims to lead the world in medical technology, seeking new insights in the healthcare field and improving the quality of diagnosis and treatment, with the purpose of realizing "The future of healthcare for all(TM)." By developing innovative technologies and services related to patient treatment and healthcare processes, BD supports those working on the front lines of healthcare. With approximately 77,000 employees worldwide, BD staff support researchers in the development of next-generation diagnostic and therapeutic methods and strive daily to enhance the safety of healthcare professionals and the efficiency of medical practices in clinical settings. By partnering with healthcare institutions in countries around the world and addressing global priority issues, BD contributes to improving healthcare outcomes, reducing costs, increasing efficiency, enhancing safety, and promoting access to healthcare through close collaboration with its customers, the healthcare institutions.